Anna Komarova

Anna Komarova

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ZBZ.A. Bagateliya
Z.A. Bagateliya
DGD.N. Grekov
D.N. Grekov
AKAnna Komarova
Anna Komarova
VKV.M. Kulushev
V.M. Kulushev
NSNikolay Юрьевич Sokolov
Nikolay Юрьевич Sokolov
MLM.S. Lebedko
M.S. Lebedko
Annual number of surgeries exceeds 10 million In Russia, and this number is increasing every year. Searching for a scale or index determining the risk of postoperative complications and mortality is an important issue all over the world. The authors analyzed all available risk assessment scales for postoperative morbidity and mortality. The most significant ones in historical aspect and modern perspective grading systems were highlighted. We compared these indices with clinical recommendations and necessary preoperative preparation. Thus, these scales are valuable for surgeons and anesthesiologists to assess the risk, volume of surgical intervention and methods of preoperative management. However, they are not perfect and require improvement. Therefore, development of such scales is a priority objective of medicine in the foreseeable future.

27 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
OOOleg СЕРГЕЕВИЧ Orlov
Oleg СЕРГЕЕВИЧ Orlov
OOOleg Orlov
Oleg Orlov
DSDmitri Shchekochikhin
Dmitri Shchekochikhin
ZMZainab Magomedova
Zainab Magomedova
ABAleksandra Bogdanova
Aleksandra Bogdanova
DMDenis MD
Denis MD
Tachycardia-induced cardiomyopathy (TIC) is a reversible subtype of dilated cardiomyopathy (DCM) resulting from sustained supraventricular or ventricular tachycardia and diagnosed by the normalization of left ventricular ejection fraction (LVEF) after stable sinus rhythm restoration. The aim of this study was to determine the contribution of cardiac magnetic resonance (CMR) to the differential diagnosis of TIC and DCM with persistent atrial arrythmias in patients hospitalized for the first time with heart failure (HF) with reduced LVEF of nonischemic origin. A total of 29 patients (age: 58.2 ± 16.9 years; males: 65.5%; average EF: 37.0 ± 9.5%) with persistent atrial tachyarrhythmia and first decompensation of HF without known coronary artery diseases were included in this study. The patients successfully underwent cardioversion and were observed for 30 days. The study population was divided into groups of responders (TIC patients; N = 16), which implies achieving FF > 50% or its increase > 10% in 30 days of TIC, and non-responders (N = 13). The increase in left ventricle (LV) volumes measured using CMR was significantly higher in the non-responder group when compared with the responders (114.8 mL ± 25.1 vs. 68.1 mL ± 10.5, respectively, p < 0.05). Non-responders also demonstrated decreased interventricular septum thickness (9.1 ± 0.8 vs.11.5 ± 1.3, respectively, p < 0.05). Late gadolinium enhancement (LGE) was observed in 12 patients (41.4%). The prevalence of LGE was increased in the non-responder group (25.0% vs. 65.1%, respectively, p = 0.046). Notably, a septal mid-wall LGE pattern was found exclusively in the non-responders. Epicardial adipose tissue thickness was decreased in the non-responder group versus the TIC patients. Conclusion: Patients with TIC were found to have smaller atrial and ventricular dimensions in comparison to patients with DCM. In addition, LGE was more common in DCM patients.

12 January 2023 in Medical alphabet
Verified
Journal Article
Open access
PDF file
VLV. D. Levina
V. D. Levina
MPMaria Poltavskaya
Maria Poltavskaya
VSV. P. Sedov
V. P. Sedov
PCPetr Chomakhidze
Petr Chomakhidze
LBLarisa Bolotina
Larisa Bolotina
AGA. N. Gerasimov
A. N. Gerasimov
   Objective. To evaluate the alterations of Global longitudinsl strain (GLS) and it’s value for prediction of cardiotoxicity of low to moderate cumulative doses of anthracyclines.   Methods. Forty-nine women 50 ± 10 years old with breast cancer, treated with anthracyclines (cumulative dose of 251 ± 60 mg/m2) were enrolled in the study. Echocardiography with GLS measurement was performed at baseline, at the end of anthracycline treatment, then every 3 months during 1 year. Cardiotoxicity was defined as a decline in left ventricular ejection fraction (LVEF) of at least 10 % to ≤ 53 %.   Results. There was a significant increase in mean LVESV and LVEDV and decrease of GLS (р < 0,05) but not LVEF at 3 month post anthracycline treatment. Cardiotoxicity was detected in 8 patients (16 %) with moderate baseline risk. Absolute ≥ 4 % reduction of GLS during follow-up, GLS andpercent of it’s reduction from baseline to 3 month post-anthracycline were predictive of cardiotoxicity (AUC = 0,822 and 0,870, respectively). The reduction in GLS of >12,5 % from baseline at 3 month post anthracyclines was predictive of cardiotoxicity with sensitivity of 80 % and specificity of 95 %.   Conclusions. GLS and its reduction from baseline has shown predictive value for development of cardiotoxicity in patients with moderate risk treated with low-to moderate cumulative doses of antracyclines. Additional echocardiography with GLS assessment at 3–6 month after completion of anthracycline treatment may be recommended irrespective of cardiotoxicity risk.

8 November 2023 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
AKAnna Komarova
Anna Komarova
NLN. L. Lyakhova
N. L. Lyakhova
SCSerghei Covantsev
Serghei Covantsev
ENE. A. Naryshkina
E. A. Naryshkina
DSD. V. Slepukhova
D. V. Slepukhova
Atrial fibrillation and chronic renal failure are common diseases in the population with similar risk factors. Both conditions are independent riskfactors for the development of thromboembolic complications. There is compelling evidence to support the benefits of anticoagulant therapy for atrial fibrillation in the general population, but in patients with advanced chronic renal failure, the use of anticoagulants may be limited. A number of studies have shown conflicting results, and this topic is of interest for further discussion and a comprehensive analysis of the existing data.

22 May 2025 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
SBS.A. Bliznyuk
S.A. Bliznyuk
AKAnna Komarova
Anna Komarova
Marat EzhovMarat Ezhov
Marat Ezhov
MCMikhail Chashchin
Mikhail Chashchin
Background. Lipoprotein(a) [Lp(a)] is an independent risk factor of ischemic heart disease, peripheral atherosclerosis, ischemic stroke, and aortic valve calcification. The relationship between elevated Lp(a) and recurrent cardiovascular events (CVE) among patients who have experienced acute coronary syndrome (ACS) remains a matter of debate. Objective. To investigate the role of Lp(a) in recurrent CVE within one year after discharge in patients with ACS. Material and methods. The study included patients with ST-segment elevation acute myocardial infarction, non-ST-segment elevation myocardial infarction and unstable angina. Incidence of composite endpoint and individual events was analyzed. Results. We followed-up 446 patients over a 12-month period including 267 men (59.9%) and 179 women (40.1%). The median age was 67 years [58; 75]. The composite endpoint (recurrent ACS, repeat percutaneous coronary interventions, cardiovascular mortality) was recorded in 20.9% (n=93) of patients. The risk ratio for non-fatal CVE, adjusted for sex, age, final diagnosis, initial Killip class, troponin I, diabetes mellitus, left ventricular ejection fraction, three-vessel coronary artery disease and aortic valve stenosis was found to be 1.005 (95% CI: 1.001—1.008) for serum Lp(a). Thus, Lp(a) increase by each 1 mg/dL is associated with significantly higher risk of non-fatal CVE by 0.5%. Conclusion. Analysis of serum Lp(a) is important in patients with ACS. This lipoprotein may be considered a potential risk stratification factor for recurrent cardiovascular events within one year following ACS.

24 April 2025 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
ALA. S. Litvinenko
A. S. Litvinenko
AKAnna Komarova
Anna Komarova
NKN. M. Krivosheeva
N. M. Krivosheeva
YKYu. V. Karabach
Yu. V. Karabach
SBS. A. Bliznyuk
S. A. Bliznyuk
Introduction. Acute cerebrovascular accident (stroke) is one of the primary causes of disability in the Russian Federation and worldwide. Approximately one-quarter of strokes are recurrent, with a higher likelihood of leading to disability and mortality. One method of surgical prevention for recurrent cerebrovascular accidents is carotid endarterectomy (CEA). For symptomatic stenosis of the internal carotid artery, surgical intervention should be performed within 14 days of the onset of acute stroke [1]. Currently, the necessity and safety of performing emergency CEA within the first 24 hours of stroke onset, especially in combination with thrombolytic therapy and/or thrombectomy, remains a debated issue. Clear criteria for selecting patients for surgical intervention have not been established.Materials and methods. The study included 39 patients with ischemic stroke who were admitted to the KBC named after S.P. Botkin on the first day of their stroke and underwent carotid endarterectomy. All patients underwent neurological status evaluation using the NIHSS (National Institutes of Health Stroke Scale), modified Rankin Scale, modified Rivermead Mobility Index, brain CT, CT angiography, CT perfusion, duplex ultrasound scanning (DUS) of the brachiocephalic arteries, and lipid profile analysis.Results. Hemorrhagic transformation of the stroke focus was observed in 5 (12.8%) patients; all patients with hemorrhagic transformation underwent reperfusion therapy – thrombolysis and/or thrombectomy. Upon admission, the severity of the stroke according to the NIHSS was 8.2±0.9 points, and at discharge, it was 5.4±0.8 points, p<0.05. The mobility index according to the Rivermead Scale at discharge was 8.6±0.8 points, and the degree of disability according to the Rankin Scale at discharge was 2.7±0.2 points. Among patients who underwent CEA within the first day of ischemic stroke, the mortality rate was 12.8% (n=5). Two clinical cases are presented, demonstrating successful carotid endarterectomy in the first day of stroke in combination with reperfusion therapy.Conclusion. Carotid endarterectomy within the first day of ischemic stroke may be considered not only as a method for preventing recurrent ischemic stroke but also as a treatment method that reduces the degree of patient disability. Further studies are required to develop a patient selection algorithm for CEA within the first day of acute cerebrovascular accident (CVA) to improve the effectiveness of surgical treatment and minimize postoperative complications.